Transformation renders MDR cells more sensitive to polyunsaturated fatty acids

Area of Science:

• Molecular biology
• Cancer research
• Cell biology

Background:

• Multidrug resistance (mdr) genes are often expressed in cancer cells, contributing to treatment failure.
• Tumorigenic cell lines are derived from non-tumorigenic counterparts through oncogene activation (e.g., myc, ras).
• Polyunsaturated fatty acids (PUFAs) possess cytotoxic properties that may impact cancer cell viability.

Purpose of the Study:

• To investigate if tumorigenic multidrug resistance (mdr) cells exhibit differential sensitivity to cytotoxic polyunsaturated fatty acids (PUFAs) compared to non-tumorigenic mdr cells.
• To explore the potential role of the tumorigenic phenotype in modulating PUFA sensitivity in mdr cells.

Main Methods:

• Utilized a series of genetically related cell lines expressing mdr genes, with varying tumorigenic potential.
• Induced tumorigenicity in parental non-tumorigenic mdr cells via myc and ras oncogene transformation.
• Assessed cellular sensitivity to gamma-linolenate and eicosapentaenoate using colony forming assays.

Main Results:

• Six out of nine tumorigenic mdr cell lines demonstrated enhanced sensitivity to PUFAs compared to their non-tumorigenic counterparts.
• Clonal variability was evaluated using four ras and five myc transformed cell lines.
• A significant difference in sensitivity was observed, indicating a link between tumorigenicity and PUFA response.

Conclusions:

• The acquisition of a tumorigenic phenotype enhances the sensitivity of mdr cells to cytotoxic PUFAs.
• PUFA supplementation may represent a promising therapeutic strategy, potentially augmenting existing cancer treatments.
• These findings have potential clinical implications for PUFA-based cancer therapy regimens.